Is MRAM a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Defense and space work that sells process, not just parts, with revenue (ttm) at ~$62M. The bear case rests on the most consequential open item is litigation, and it is a patent fight rather than a shareholder suit: Avalanche Technology filed a patent infringement complaint against Everspin in the US District Court for the District of Delaware and a parallel Section 337 complaint on January 28, 2026, amended February 5, and the International Trade Commission voted to institute Investigation No. Analysts covering it are spread from $19.00 to $38.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The most consequential open item is litigation, and it is a patent fight rather than a shareholder suit: Avalanche Technology filed a patent infringement complaint against Everspin in the US District Court for the District of Delaware and a parallel Section 337 complaint on January 28, 2026, amended February 5, and the International Trade Commission voted to institute Investigation No. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $19.00, +0.6% from the $18.88 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Defense and space work that sells process, not just parts. In late April 2026 Everspin executed a $40 million agreement covering roughly two and a half years, acting as subcontractor on an existing prime contract to supply Toggle MRAM process technology, engineering and foundry services to United States Defense Industrial Base customers. The most optimistic analyst target on MRAM is $38.00, +101.3% from the $18.88 price. That figure is only reachable if this thesis works close to its best case.

The most consequential open item is litigation, and it is a patent fight rather than a shareholder suit: Avalanche Technology filed a patent infringement complaint against Everspin in the US District Court for the District of Delaware and a parallel Section 337 complaint on January 28, 2026, amended February 5, and the International Trade Commission voted to institute Investigation No. 337-TA-1487 on February 27, 2026 before Administrative Law Judge Doris Johnson Hines, asserting 37 claims across four patents and requesting an exclusion order plus a cease and desist order that would bar importation of Everspin's STT-MRAM products. Everspin has stated the claims reach the STT-MRAM line only and not Toggle MRAM or sensor devices, and that it believes it has strong defenses and will contest them; a Section 337 investigation typically concludes 14 to 16 months from institution, so resolution is unlikely before roughly mid-2027, and defense costs are one reason the GAAP loss widened to ~$3.6 million in a quarter when revenue and gross margin both improved. Beyond the case, revenue is small and lumpy, a handful of industrial and defense customers and one prime-contract agreement account for a meaningful share of it, and wafer supply depends on GlobalFoundries under an arrangement that grants exclusivity on certain STT-MRAM nodes. Valuation carries its own exposure, since ~7.4 times trailing sales with GAAP losses already prices the data-center and defense roadmap converting rather than merely being demonstrated, and the trading character compounds it: the shares ran from $5.76 to $51.50 and back under $20 within twelve months, a leveraged single-stock ETF now trades against them, and realised volatility of that order is not proportional to changes in the underlying business. The most pessimistic published target is $19.00, +0.6% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Everspin Technologies builds magnetoresistive RAM (MRAM) and the tunnel magnetoresistance sensors that share its magnetic process, from Chandler, Arizona.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Defense and space work that sells process, not just parts) stalling in the reported numbers rather than in the narrative, the risk above (the most consequential open item is litigation, and it is a patent fight rather than a shareholder suit: Avalanche Technology filed a patent infringement complaint against Everspin in the US District Court for the District of Delaware and a parallel Section 337 complaint on January 28, 2026, amended February 5, and the International Trade Commission voted to institute Investigation No) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Both, which causes regular confusion. MRAM stands for magnetoresistive random access memory, a memory type that stores bits magnetically and keeps them without power, and Everspin Technologies happens to trade under MRAM on the Nasdaq Global Market because it is the largest commercial supplier of that memory. Searches for the ticker frequently return technology explainers rather than company filings.

Everspin is a US-listed common stock on the Nasdaq Global Market, so it is available through any standard US brokerage account, and several brokers support fractional purchases given the share price near $18.88 in mid-August 2026. Indirect exposure also exists: the company joined the Russell 2000 index effective June 29, 2026, so small-cap index funds tracking that benchmark hold a position. A 2x leveraged single-stock ETF on Everspin began trading in August 2026, a structure whose daily reset makes it behave differently from the shares over any period longer than a day.

Not on a GAAP basis in the most recent quarter. June-quarter results showed a GAAP net loss of ~$3.6 million, or ~$0.15 per share, alongside non-GAAP net income of ~$2.9 million, or ~$0.11 per diluted share, with the gap explained mainly by stock compensation and legal expense. Trailing twelve-month GAAP net income was around negative $2.6 million and free cash flow was slightly negative. Everspin has not paid a dividend and retains its cash.